Tianjin Lisheng Pharmaceutical Co., Ltd. Class ASZSE: 002393

Tianjin Development Posts FY Net Profit Attributable Guidance For Tianjin Lisheng Pharmaceutical

· Issued by Tianjin Lisheng Pharmaceutical Co., Ltd. Class A

Tianjin Lisheng Pharmaceutical Co Ltd SZSE:002393:

  • SEES FY NET PROFIT ATTRIBUTABLE FOR TIANJIN LISHENG PHARMACEUTICAL RMB400 MILLION TO RMB440 MILLION

Earlier from Tianjin Lisheng Pharmaceutical Co., Ltd. Class A

All Tianjin Lisheng Pharmaceutical Co., Ltd. Class A news releases